check_circleStudy Completed

Female contraception

DRSP wafer: rel. BA vs. Yaz

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

45 - 75 Years
  • -

  • -

Trial summary

Enrollment Goal
18
Trial Dates
March 2009 - June 2009
Phase
Phase 1
Could I Receive a placebo
N/A
Products
DRSP Ring (BAY86-4888)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Terminated
Scope InternationalHamburg, 22525, Germany
Completed
Bayer Pharma AGBerlin, 13353, Germany

Trial design

An open-label, single-dose, randomized, 3-fold crossover study investigating the relative bioavailability of drospirenone (DRSP) and ethinylestradiol (EE) after oral single dose administrations of 3 mg DRSP and 0.02 mg EE as two different wafer formulations versus as a marketed tablet in 18 healthy postmenopausal women
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A